By: Kevin Cho
Tustin, CA - Integrium, LLC announced they will be attending the 2018 Biotechnology Innovation Organization (BIO) International Convention located in Boston, CA on June 4-6. Integrium is looking forward to joining other industry thought leaders and pharmaceutical companies to fulfill networking goals and potential partnerships.
The key benefits of attending the BIO International Convention is to gain exposure to biotechnology and pharmaceutical leaders and opportunities to network with 16,000+ attendees from 74 countries. For more information, or to register, please see BIO’s website (http://convention.bio.org/)
Integrium Executives will be taking meetings throughout BIO and encourage guests to schedule meeting requests with Mike Loftus, Executive Director of Business Development and other companies attending BIO. Please contact email@example.com to schedule time with Integrium during BIO.
Integrium helps Micro Cap, Small Cap, and Privately held Biotechs within the Innovator and Generic space attain clinical data so they can raise the next round of capital. Integrium’s areas of therapeutic focus include Cardiovascular, Metabolic, Renal, Inflammatory, Dermatology, Wound Healing, Gene Therapy, and Orphan Diseases. Secondary specialties include Schedule 2 drugs and Oncology.
Check out our new website!
To learn more about Integrium, contact:
Business Development Analyst